SuperworthIDEXX Laboratories shares outstanding IDXX
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Jun 30, 2026
- 79.3M
- On a year earlier
- −2.1%
- fewer shares
IDEXX Laboratories had 79.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.1% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 80.5M | −3% |
| FY2024 | 82.6M | −2% |
| FY2023 | 83.9M | +0% |
| FY2022 | 83.8M | −3% |
| FY2021 | 86.2M | −1% |
| FY2020 | 87M | −0% |
| FY2019 | 87.3M | −1% |
| FY2018 | 87.8M | −1% |
| FY2017 | 89.1M | −2% |
| FY2016 | 90.7M | −1% |
| FY2015 | 91.8M | −5% |
| FY2014 | 96.9M | −8% |
| FY2013 | 105.6M | −5% |
| FY2012 | 111.6M | −2% |
| FY2011 | 113.9M | −4% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 79.3M | −2% | |
| Q1 FY26 | 80.2M | −2% | |
| Q4 FY25 | 80.5M | −3% | |
| Q3 FY25 | 80.7M | −3% | |
| Q2 FY25 | 81M | −3% | |
| Q1 FY25 | 81.9M | −2% | |
| Q4 FY24 | 82.6M | −2% | |
| Q3 FY24 | 83.1M | −1% | |
| Q2 FY24 | 83.4M | −1% | |
| Q1 FY24 | 84M | −0% | |
| Q4 FY23 | 83.9M | +0% | |
| Q3 FY23 | 84M | −0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on IDEXX Laboratories
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.